Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
Age
18–65
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
A positive diagnosis of IBS.
Subjects must either have been surgically sterilized, hysterectomized at least 6 months prior to screening, be postmenopausal or be using a double-barrier local
contraception.
Able to communicate well with the investigator, to understand and comply with the requirements of the study. Understand and sign the written informed consent
You may not be if
History of or evidence for structural diseases/conditions that affect the gastrointestinal system.
Other diseases or conditions that in the opinion of the Investigator significantly affect colorectal sensitivity.
Evidence of occult blood at stool analysis, or history of rectal bleeding.
Using or planning to use drugs or agents during the study period that alter GI physiology and visceral perception.
Clareo Health | Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide
